ID: ALA5287243

Max Phase: Preclinical

Molecular Formula: C20H28N10O14P2

Molecular Weight: 694.45

Associated Items:

Representations

Canonical SMILES:  NC1=NC2C(N=CN2[C@@H]2O[C@@H]3COP(=O)(O)O[C@H]4[C@@H](O)[C@H](N5C=NC6C(=O)NC(N)=NC65)O[C@@H]4COP(=O)(O)O[C@H]3[C@H]2O)C(=O)N1

Standard InChI:  InChI=1S/C20H28N10O14P2/c21-19-25-13-7(15(33)27-19)23-3-29(13)17-9(31)11-5(41-17)1-39-45(35,36)44-12-6(2-40-46(37,38)43-11)42-18(10(12)32)30-4-24-8-14(30)26-20(22)28-16(8)34/h3-14,17-18,31-32H,1-2H2,(H,35,36)(H,37,38)(H3,21,25,27,33)(H3,22,26,28,34)/t5-,6-,7?,8?,9-,10-,11-,12-,13?,14?,17-,18-/m1/s1

Standard InChI Key:  APDCWWDAKYCZGK-DCNAHEOSSA-N

Associated Targets(Human)

Stimulator of interferon genes protein 1885 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L929 3802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 694.45Molecular Weight (Monoisotopic): 694.1262AlogP: -5.86#Rotatable Bonds: 2
Polar Surface Area: 336.60Molecular Species: ACIDHBA: 20HBD: 8
#RO5 Violations: 3HBA (Lipinski): 24HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.51CX Basic pKa: 5.35CX LogP: -5.73CX LogD: -9.33
Aromatic Rings: 0Heavy Atoms: 46QED Weighted: 0.12Np Likeness Score: 0.64

References

1. Zhang J, Zhang Y, Qu B, Yang H, Hu S, Dong X..  (2021)  If small molecules immunotherapy comes, can the prime be far behind?,  218  [PMID:33773287] [10.1016/j.ejmech.2021.113356]

Source